China authorizes Livzon Pharma’s COVID-19 vaccine for emergency use
New protein-based vaccine to be used as booster jab, local media reports.
Abone Ol
China has approved Livzon Pharmaceutical Group's COVID-19 vaccine for emergency use, local media reported on Saturday.
Livzon’s protein-based vaccine is the eighth domestically developed vaccine that will be used as a booster shot in the country where nearly 90% of the population have received their primary vaccinations, according to Caixin Global’s website.
Most Read News
-
China rescues 580 hikers from Mount Everest
-
Zelenskyy accuses Russia of using ‘shadow fleet’ for int
-
US Senate confirms 107 Trump nominees under new rules
-
French National Assembly rejects motion to impeach Presi
-
Israel kills 118 Palestinians in Gaza over past 4 days:
-
Putin claims Russia took control of nearly 5,000 square
-
US envoy Witkoff, Kushner arrive in Egypt for Gaza cease
-
Israeli Navy attacks Gaza-bound Freedom Flotilla Coaliti
-
Attack on Freedom Flotilla in int'l waters 'act of pirac
